Durapren 0.75%

Product NDC: 70529-007
11-digit product format: 705290007
Labeler code: 70529
Product ID: 70529-007_3aa7bb56-b73a-456b-ae3b-78ca9606cb58
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: BUPIVACAINE HYDROCHLORIDE
Dosage form: INJECTION, SOLUTION
Route: EPIDURAL; RETROBULBAR
Labeler: IT3 Medical LLC
Application: NDA016964
Marketing category: NDA
Marketing start: 2017-03-01
Marketing end: 0000-00-00
Substance: BUPIVACAINE HYDROCHLORIDE
Active strength: 8 mg/mL
Pharmacologic classes: Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	70529-007		I	Inactivated by FDA		2026-10-05
excluded package	package	70529-007	70529-007-01	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 30 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70529-007-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70529-007-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70529-007-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70529-007-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70529-007-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70529-007-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70529-007-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70529-007-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70529-007-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	70529-007-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	70529-007-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	70529-007-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	70529-007-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	70529-007-01	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	70529-007-01	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 10 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS
N016964-001	MARCAINE HYDROCHLORIDE	BUPIVACAINE HYDROCHLORIDE	0.25%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982
N016964-004	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	0.25%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982
N016964-005	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	BUPIVACAINE HYDROCHLORIDE	0.5%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982
N016964-006	MARCAINE HYDROCHLORIDE	BUPIVACAINE HYDROCHLORIDE	0.5%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982
N016964-007	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	0.5%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982
N016964-008	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	0.5%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982
N016964-009	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	BUPIVACAINE HYDROCHLORIDE	0.75%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982
N016964-010	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	0.75%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982
N016964-012	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	BUPIVACAINE HYDROCHLORIDE	0.25%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982
N016964-013	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	0.25%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 10 matching rows.

Application-product, TE code table
Application-product	TE code
N016964-001	AP
N016964-004	AP
N016964-005	AP
N016964-006	AP
N016964-007	AP
N016964-008	AP
N016964-009	AP
N016964-010	AP
N016964-012	AP
N016964-013	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 11 · 430 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Source SHA-256
2026-09-14 22:38:34	2026-08	N016964-001	MARCAINE HYDROCHLORIDE	0.25%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-004	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	0.25%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-005	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.5%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-006	MARCAINE HYDROCHLORIDE	0.5%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-007	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.5%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-008	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	0.5%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-009	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.75%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-010	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.75%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-012	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.25%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-013	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.25%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N016964-001	MARCAINE HYDROCHLORIDE	0.25%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-004	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	0.25%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-005	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.5%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-006	MARCAINE HYDROCHLORIDE	0.5%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-007	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.5%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-008	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	0.5%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-009	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.75%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-010	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.75%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-012	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.25%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-013	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.25%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N016964-001	MARCAINE HYDROCHLORIDE	0.25%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-004	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	0.25%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-005	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.5%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-006	MARCAINE HYDROCHLORIDE	0.5%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-007	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.5%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-008	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	0.5%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-009	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.75%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-010	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.75%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-012	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.25%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-013	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.25%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-001	MARCAINE HYDROCHLORIDE	0.25%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-004	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	0.25%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-005	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.5%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-006	MARCAINE HYDROCHLORIDE	0.5%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-007	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.5%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-008	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE	0.5%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-009	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.75%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-010	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.75%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-012	MARCAINE HYDROCHLORIDE PRESERVATIVE FREE	0.25%	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-013	MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE	0.25%;0.0091MG/ML	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 11 · 430 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N016964-001	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-004	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-005	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-006	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-007	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-008	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-009	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-010	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-012	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N016964-013	AP	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N016964-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-004	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-005	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-006	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-007	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-008	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-009	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-010	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-012	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N016964-013	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N016964-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-004	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-005	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-006	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-007	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-008	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-009	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-010	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-012	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N016964-013	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-004	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-005	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-006	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-007	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-008	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-009	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-010	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-012	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016964-013	AP	1	`31067a03dcf5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cbf85893-59ef-423f-87d4-a573c000a8b9	Product name	8	20250731
5dad6767-dcd1-b0da-8727-7f3f7bc3a435	Product name	2	20250303
e3a99641-4540-4894-9108-00cab3c57b7e	Product name	1	20211207
5da98533-f072-406b-9e1b-6ac19eca9926	Product name	1	20210622
306b993e-3140-4823-ad5e-88b708f9d2ac	Product name	1	20210510
a831e694-3663-4a83-82be-6c309429f750	Product name	2	20200608

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
70529-007-01	2023-07-28	C162847	48780-1	d6a99b39-85e9-a426-e053-dadaa90af4c2	Durapren 0.75% Injection System
70529-007-01	2022-03-01	C162847	48780-1	d6a99b39-85e9-a426-e053-dadaa90af4c2	Durapren 0.75% Injection System
70529-007-01	2022-01-28	C162847	48780-1	d6a99b39-85e9-a426-e053-dadaa90af4c2	Durapren 0.75% Injection System

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
70529-007-01	Durapren 0.75%	30 mL in 1 VIAL, SINGLE-DOSE	INJECTION, SOLUTION	30		3
70529-007-01	Durapren 0.75%	1 in 1 PACKAGE	INJECTION, SOLUTION	1		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70529-007	DURAPREN 0.75% (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [IT3 MEDICAL LLC]	3	Legacy NDC, 2 package rows	20220302_290b9588-05a0-457e-bc65-7684eaff4057.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Marcaine	BUPIVACAINE HYDROCHLORIDE	Henry Schein, Inc.	562f4499-f3b7-4d9e-b022-61172176c883	2026-06-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 016964 application number: NDA016964
Marcaine	BUPIVACAINE HYDROCHLORIDE	Henry Schein, Inc.	2c6f9b85-e783-4ad4-a804-a0ff1a32ec2c	2026-06-24	Warnings, Adverse reactions	Exact identifier application applno (NDA): 016964 application number: NDA016964
Marcaine	BUPIVACAINE HYDROCHLORIDE	Hospira, Inc.	67578b56-7540-487e-1fba-481255620e78	2026-05-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 016964 application number: NDA016964
MARCAINE WITH EPINEPHRINE	BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE	Henry Schein, Inc.	d0d51133-882c-4f9e-ba1c-f037226305a1	2026-01-28	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 016964 application number: NDA016964
Marcaine	BUPIVACINE HYDROCHLORIDE	Henry Schein, Inc.	7d94e8e0-0d1e-4af3-973a-a480d7d51737	2026-01-26	Warnings, Adverse reactions	Exact identifier application applno (NDA): 016964 application number: NDA016964
Marcaine with Epinephrine	BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	Hospira, Inc.	93cf0914-de08-4ec6-8f8c-d663243b9958	2024-02-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 016964 application number: NDA016964

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7TQO7W3VT8	BUPIVACAINE HYDROCHLORIDE	73360-54-0	BUPIVACAINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1724786	BUPivacaine HCl 0.75 % in 30 ML Injection	PSN	290b9588-05a0-457e-bc65-7684eaff4057	3
1724786	30 ML bupivacaine hydrochloride 7.5 MG/ML Injection	SCD	290b9588-05a0-457e-bc65-7684eaff4057	3
1724786	bupivacaine HCl 0.75 % in 30 ML Injection	SY	290b9588-05a0-457e-bc65-7684eaff4057	3
1724786	bupivacaine HCl 225 MG per 30 ML Injection	SY	290b9588-05a0-457e-bc65-7684eaff4057	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
70529-007-01	70529000701	1 VIAL, SINGLE-DOSE in 1 PACKAGE (70529-007-01) > 30 mL in 1 VIAL, SINGLE-DOSE	2017-03-01	0000-00-00	No	No	Current